Discover Financial Services  (DFS)
Other Ticker:  
Price: $68.0000 $1.84 2.781%
Day's High: $67.75 Week Perf: 6.99 %
Day's Low: $ 66.41 30 Day Perf: 27.96 %
Volume (M): 322 52 Wk High: $ 87.43
Volume (M$): $ 21,720 52 Wk Avg: $60.15
Open: $65.36 52 Wk Low: $23.25

 Market Capitalization (Millions $) 20,853
 Shares Outstanding (Millions) 307
 Employees 14,676
 Revenues (TTM) (Millions $) 5,906
 Net Income (TTM) (Millions $) 1,049
 Cash Flow (TTM) (Millions $) 3,814
 Capital Exp. (TTM) (Millions $) 286

Discover Financial Services
We are a leading credit card issuer and electronic payment services company with one of the most recognized brands in U.S. financial services. Since our inception in 1986, we have grown to become one of the largest card issuers in the United States. We are also a leader in payments processing, as we are one of only two credit card issuers with its own U.S. payments network and the only issuer whose wholly-owned network operations include both credit and debit functionality. We issue credit cards in the United States under the Discover Card brand to various segments within the consumer and small business sectors. Most of our cards offer a Cashback Bonus rewards program. In addition, we offer a range of banking products to our customers, including personal loans, student loans, certificates of deposit and money market accounts.

   Company Address: 2500 Lake Cook Road Riverwoods 60015 IL
   Company Phone Number: 405-0900   Stock Exchange / Ticker: NYSE DFS
   DFS is expected to report next financial results on February 08, 2021. Next quarterly dividend payout on January 21, 2021.

Discover Financial Services's Segments
U.S. Card
 Segment    83.47 % of total Revenue
Private student loans
 Segment    4.73 % of total Revenue
PCI student loans
 Segment    2.69 % of total Revenue
Personal loans
 Segment    8.02 % of total Revenue
 Segment    1.1 % of total Revenue

Discover Financial Services's Operating Statistics Decrease / Increase
Interest rate spread 8.04    Interest rate spread Growth  6.35 % 
Net Interest Margin 9.81    Net Interest Margin Growth  3.92 % 
Nonperforming Assets Ratio 0.00   
Allowance for Credit Losses 0.00   
Tier1 Capital Ratio 0.00   
Total Capital Ratio 0.00   
Leverage Ratio 0.00   
Tangible Common Equity Ratio 12.77 -5.59 %  Tangible Common Equity Ratio Decline   
Efficiency Ratio 40.31    Efficiency Ratio Growth  6.75 % 
• View Complete Report

Monaker Group Inc

Monaker Group Inc announced second quarter of 2020 operating loss of $-2.357003 millions

In the second quarter of 2020 Monaker Group Inc lost money of $-0.20 per share compared to $-0.36 a year ago and increased losses from $-0.15 per share from the previous quarter.

Sales fell sharply by -86.06% to $0.03 millions from $0.25 millions in the same quarter a year ago and sequentially Sales doubled by 338.72 % from $0.01 millions.

Patriot Scientific Corp

Sales and Earnings Unchanged

Patriot Scientific Corp announced operating deficit of $-0.111807 millions, in the first quarter of 2020, an advancement from the operating loss of $-0.303037 millions, recorded in the same quarter a year ago.

United Airlines Holdings Inc

Deficit Widen, Topline Tumbles

United Airlines Holdings Inc reported disastrous third quarter of 2020, where Sales faded by -78.13% to $2.49 billions and loss per share has widen at $-6.33, from the same quarter a year ago.

from the preceding quarter from $-5.79 per share, Sales surged by 68.75 % from $1.48 billions.

Brainstorm Cell Therapeutics inc

Brainstorm Cell Therapeutics Inc announced third quarter of 2020 operating shortfall of $-4.485 millions

In the third quarter of 2020 Brainstorm Cell Therapeutics Inc decreased loss of $-0.14 per share compared to $-0.25 a year ago and improved from $-0.25 per share from the previous quarter.

Brainstorm Cell Therapeutics Inc reported operating deficit of $-4.485 millions, in the third quarter of 2020, an improvement from the operating loss of $-5.551 millions, realized in third quarter of 2019

Lexaria Bioscience Corp

Loss Despite Sales Growth

Lexaria Bioscience Corp announced earnings per share of $-0.01 and Sales of $0.09 millions in the fourth quarter of 2020, Company's lost money per share, versus $-0.01 eps, earned in the same quarter a year ago, although Lexaria Bioscience Corp saw its Sales rise by 1.09% in the same period.

In comparison to previous quarter improved from $-0.02 per share and Sales surged by 49.16 % from $0.09 millions.

Customers Net Income fell by DFS's customers Net margin fell to 0 %
-50.22 % 14.91 %
• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers

Major Competitors Stock performance

5 Days Decrease / Increase
V   -1.12%    
SYF   -100%    
SLM        1.59% 
NAVI   -100%    
MA   -2.88%    
AXP   -3.75%    
• View Complete Report


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production


Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales


Event Calendar

ALTA's Profile

Stock Price

ALTA's Financials

Business Description


Charts & Quotes

ALTA's News


ALTA's Competitors

Customers & Markets

Economic Indicators

ALTA's Growth

Company Segments


Stock Performance

Growth Rates




Financial Strength


Largest Companies

Management Effectivness


At a Glance


Growth Rates



Financial Strength


At a Glance



Sectors & Industries





At a Glance








About us


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071